Alzheimer's Disease: Optimizing the Development of the Next Generation of Therapeutic Compounds - Couverture rigide
Synopsis
Alzheimer's disease (AD) is a progressively degenerative form of dementia in which impaired cognitive functioning is the earliest and most prominent clinical "symptom". While much has been learned about the disease process itself, progress in treatment has been slow and the search for new and more effective therapies is intensifying rapidly. This book provides a broad scientific readership with a critical assessment of the impact that the next generation of drug treatments in AD will have, based on empirical data from recent and ongoing clinical trials. Information is presented clearly and concisely, and this book should be valuable to any researcher or clinician with an interest in AD.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour Alzheimer's Disease: Optimizing the Development...
Image fournie par le vendeur
Alzheimer's Disease: Optimizing the Development of the Next Generation of Therapeutic Compounds (Greenwich Medical Media)
Edité par
Oxford University Press, 1998
ISBN 10 : 1841100064
ISBN 13 : 9781841100067
Ancien ou d'occasion
Couverture rigide
Vendeur : CorgiPack, Fulton, NY, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Hardcover. Etat : VG. Text free of underlining, writing and highlighting. Alzheimer's disease (AD) is a progressively degenerative form of dementia in which impaired cognitive functioning is the earliest and most prominent clinical 'symptom'. While much has been learned about the disease process itself, progress in treatment has been slow and the search for new and more effective therapies is intensifying rapidly. This book critically assesses the impact of the next generation of drug treatments in AD. It will serve as a valuable reference source for clinical researchers involved in all aspects of drug development in AD including neurologists, psychiatrists, geriatricians, psychologists, psychopharmacologists, clinical pharmacologists and all those involved in the design and analysis of pharmaceutical trials. ' 208 pages. N° de réf. du vendeur WBM017345
Acheter D'occasion
EUR 10,67
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)